142 related articles for article (PubMed ID: 20851657)
41. [TNF-alpha antibody in rheumatoid arthritis. Efficacy-risk relationship is positively evaluated].
MMW Fortschr Med; 2002 May; 144(20):65. PubMed ID: 12119893
[No Abstract] [Full Text] [Related]
42. Onset of inflammatory eye disease under tocilizumab treatment for rheumatologic conditions: a paradoxical effect?
Wendling D; Dernis E; Prati C; Frisch E; Delbosc B
J Rheumatol; 2011 Oct; 38(10):2284. PubMed ID: 21965707
[No Abstract] [Full Text] [Related]
43. Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy.
Snir A; Kessel A; Haj T; Rosner I; Slobodin G; Toubi E
Clin Exp Rheumatol; 2011; 29(4):697-700. PubMed ID: 21813064
[TBL] [Abstract][Full Text] [Related]
44. Clinical pharmacology of tocilizumab for the treatment of patients with rheumatoid arthritis.
Zhang X; Peck R
Expert Rev Clin Pharmacol; 2011 Sep; 4(5):539-58. PubMed ID: 22114882
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-6 inhibition and clinical efficacy in rheumatoid arthritis treatment--data from randomized clinical trials.
Kavanaugh A
Bull NYU Hosp Jt Dis; 2007; 65 Suppl 1():S16-20. PubMed ID: 17708740
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor-associated palmoplantar pustular psoriasis treated with interleukin 6 blocker.
Younis S; Rimar D; Slobodin G; Rosner I
J Rheumatol; 2012 Oct; 39(10):2055-6. PubMed ID: 23028035
[No Abstract] [Full Text] [Related]
47. Tocilizumab for the treatment of rheumatoid arthritis.
Tanaka T; Ogata A; Narazaki M
Expert Rev Clin Immunol; 2010 Nov; 6(6):843-54. PubMed ID: 20979549
[TBL] [Abstract][Full Text] [Related]
48. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
49. FDA approves tocilizumab to treat rheumatoid arthritis.
Thompson CA
Am J Health Syst Pharm; 2010 Feb; 67(4):254. PubMed ID: 20133526
[No Abstract] [Full Text] [Related]
50. A pilot study of endothelial dysfunction and aortic stiffness after interleukin-6 receptor inhibition in rheumatoid arthritis.
Protogerou AD; Zampeli E; Fragiadaki K; Stamatelopoulos K; Papamichael C; Sfikakis PP
Atherosclerosis; 2011 Dec; 219(2):734-6. PubMed ID: 21968316
[TBL] [Abstract][Full Text] [Related]
51. Varicella-Zoster virus hip arthritis in a rheumatoid arthritis patient.
Senlis M; Ottaviani S; Gardette A; Palazzo E; Coustet B; Dieudé P
Joint Bone Spine; 2017 Mar; 84(2):241-242. PubMed ID: 27269653
[No Abstract] [Full Text] [Related]
52. Aseptic meningitis possibly induced by adalimumab.
Jazeron A; Lallier JC; Rihn B; Thiercelin MC
Joint Bone Spine; 2010 Dec; 77(6):618-9. PubMed ID: 20656540
[No Abstract] [Full Text] [Related]
53. Tocilizumab (Actemra) for rheumatoid arthritis.
Med Lett Drugs Ther; 2010 Jun; 52(1340):47-8. PubMed ID: 20539266
[No Abstract] [Full Text] [Related]
54. Ustekinumab and herpes zoster.
Failla V; Nikkels AF
Dermatology; 2011; 222(2):119-22. PubMed ID: 21266799
[TBL] [Abstract][Full Text] [Related]
55. Dermatomyositis during adalimumab therapy for rheumatoid arthritis.
Brunasso AM; Scocco GL; Massone C
J Rheumatol; 2010 Jul; 37(7):1549-50. PubMed ID: 20595297
[No Abstract] [Full Text] [Related]
56. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
Gabriel SE
Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805
[No Abstract] [Full Text] [Related]
57. [Tocilizumab in rheumatoid arthritis].
Rueda Gotor J; Blanco Alonso R
Reumatol Clin; 2011 Mar; 6S3():S29-32. PubMed ID: 21794769
[TBL] [Abstract][Full Text] [Related]
58. Tocilizumab in the treatment of rheumatoid arthritis: an evidence-based review and patient selection.
Biggioggero M; Crotti C; Becciolini A; Favalli EG
Drug Des Devel Ther; 2019; 13():57-70. PubMed ID: 30587928
[TBL] [Abstract][Full Text] [Related]
59. [Immunosuppression may mask severe infection. Septic arthritis in tocilizumab treatment yielded only modest acute-phase reaction].
Ljung L; Smeds J; Persson G; Jirlén L; Toolanen G
Lakartidningen; 2012 Sep 19-26; 109(38):1678-9. PubMed ID: 23094399
[No Abstract] [Full Text] [Related]
60. [Cutaneous rash from the use of medicine for rheumatoid arthritis].
Hannuksela M
Duodecim; 2006; 122(1):105, 111. PubMed ID: 16509198
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
